Published in Transfusion on September 01, 1995
Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J Clin Microbiol (2005) 1.24
Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol (2001) 0.93
Definition of false-positive reactions in screening for hepatitis C virus antibodies. J Clin Microbiol (1999) 0.92
Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis. J Clin Microbiol (1998) 0.91
Hepatitis C virus infection among transmission-prone medical personnel. Eur J Clin Microbiol Infect Dis (2011) 0.89
Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera. J Clin Microbiol (1996) 0.82
Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review. World J Virol (2015) 0.82
Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther (2009) 0.80
Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999. Clin Diagn Lab Immunol (2002) 0.79
Laboratory diagnosis of viral hepatitis C: The Sultan Qaboos University Hospital experience. J Sci Res Med Sci (2003) 0.77
Fluctuating antibody response in a cohort of hepatitis C patients. J Sci Res Med Sci (2002) 0.75
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
Sexual transmission of hepatitis C virus. Lancet (1993) 4.27
Hepatitis C virus six years on. Lancet (1994) 4.09
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. Vox Sang (2005) 2.77
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J (1985) 2.47
Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates. Lancet (1992) 2.44
Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41
Early detection of antibodies to HIV-1 by third-generation assays. Lancet (1992) 2.18
The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell (1986) 2.06
Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C. Ann Intern Med (1996) 2.05
Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus. Lancet (1986) 2.04
Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet (1979) 2.03
Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol (1994) 2.02
Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J (Clin Res Ed) (1983) 1.86
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol (1991) 1.83
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet (1989) 1.82
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis (2005) 1.80
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue. J Virol Methods (1994) 1.62
Cloned human snRNP proteins B and B' differ only in their carboxy-terminal part. EMBO J (1989) 1.59
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill (2013) 1.51
Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol (1992) 1.49
Hepatitis E in The Netherlands: imported and endemic. Lancet (1993) 1.45
Remuneration of blood donors: new proof of the pudding? Vox Sang (2008) 1.44
Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection. Vox Sang (1989) 1.43
Cord blood banking. Vox Sang (2008) 1.41
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41
[Hepatitis C; a new virus for an old disease]. Ned Tijdschr Geneeskd (1992) 1.40
[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Ned Tijdschr Geneeskd (2005) 1.39
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion (1998) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results. Transfusion (1997) 1.38
Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis. Eur J Gastroenterol Hepatol (1999) 1.37
Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines. J Gen Virol (1987) 1.36
Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. EMBO J (1987) 1.36
Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J (1989) 1.35
Donors with a rare pheno (geno) type. Vox Sang (2008) 1.35
Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol (1992) 1.33
Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes. J Virol (1986) 1.24
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood. Lancet (1986) 1.18
Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18
Evaluation of a new haemagglutination technique for the demonstration of hepatitis-B antigen. Lancet (1973) 1.18
Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial. Lancet (1983) 1.17
Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang (2011) 1.16
Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang (1991) 1.15
The primary structure of leucine aminopeptidase from bovine eye lens. J Biol Chem (1982) 1.14
Amplified-fragment length polymorphism analysis of Propionibacterium isolates implicated in contamination of blood products. Br J Haematol (2005) 1.13
High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients. Vox Sang (1998) 1.09
Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion (1993) 1.09
Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. Euro Surveill (2012) 1.08
[Influenza in children undergoing chemotherapy]. Ned Tijdschr Geneeskd (2007) 1.08
Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang (1992) 1.08
[Molecular genetic studies in alpha-thalassemia]. Ned Tijdschr Geneeskd (1992) 1.07